TipRanks
Grand Pharmaceutical Group Limited (HK:0512)
:0512
Hong Kong Market
0512
Grand Pharmaceutical Group Limited
RESEARCH TOOLSreports
Want to see HK:0512 full AI Analyst Report?

Grand Pharmaceutical Group Limited (0512) Ratios

5 Followers

Grand Pharmaceutical Group Limited Ratios

HK:0512's free cash flow for Q2 2026 was HK$0.53. For the 2026 fiscal year, HK:0512's free cash flow was decreased by HK$ and operating cash flow was HK$0.17. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.34 1.14 1.22 1.22 1.07
Quick Ratio
 1.10 0.93 1.01 0.98 0.86
Cash Ratio
 0.11 0.16 0.20 0.23 0.22
Solvency Ratio
 0.17 0.18 0.35 0.31 0.30
Operating Cash Flow Ratio
 0.25 0.21 0.29 0.42 0.30
Short-Term Operating Cash Flow Coverage
 0.92 0.53 0.61 1.05 0.59
Net Current Asset Value
HK$ -2.56BHK$ -1.68BHK$ -440.31MHK$ -228.66MHK$ -1.28B
Leverage Ratios
Debt-to-Assets Ratio
 0.18 0.17 0.18 0.15 0.20
Debt-to-Equity Ratio
 0.29 0.28 0.27 0.22 0.32
Debt-to-Capital Ratio
 0.23 0.22 0.21 0.18 0.24
Long-Term Debt-to-Capital Ratio
 0.16 0.10 0.07 0.06 0.08
Financial Leverage Ratio
 1.63 1.60 1.52 1.49 1.58
Debt Service Coverage Ratio
 1.13 0.70 0.91 1.00 0.79
Interest Coverage Ratio
 9.11 6.42 12.05 12.98 18.31
Debt to Market Cap
 0.30 0.17 0.26 0.24 0.27
Interest Debt Per Share
 1.49 1.39 1.32 1.03 1.30
Net Debt to EBITDA
 1.88 1.51 0.92 0.70 0.98
Profitability Margins
Gross Profit Margin
52.11%55.20%57.86%61.96%62.24%
EBIT Margin
13.44%14.38%24.77%24.45%28.22%
EBITDA Margin
18.58%19.12%29.09%28.17%32.35%
Operating Profit Margin
11.51%8.49%18.65%25.29%26.33%
Pretax Profit Margin
11.18%12.16%24.49%22.26%26.32%
Net Profit Margin
9.02%10.10%21.20%17.85%21.75%
Continuous Operations Profit Margin
9.07%10.13%21.18%18.00%21.94%
Net Income Per EBT
80.71%83.05%86.54%80.20%82.62%
EBT Per EBIT
97.08%143.32%131.32%88.02%99.97%
Return on Assets (ROA)
4.03%4.57%9.88%8.35%9.30%
Return on Equity (ROE)
6.61%7.29%14.98%12.40%14.71%
Return on Capital Employed (ROCE)
6.57%5.25%11.79%15.87%15.82%
Return on Invested Capital (ROIC)
4.95%3.82%8.71%11.25%10.95%
Return on Tangible Assets
4.93%5.58%11.66%9.27%10.56%
Earnings Yield
6.83%4.51%14.69%13.40%12.76%
Efficiency Ratios
Receivables Turnover
 2.31 2.59 4.18 4.68 4.33
Payables Turnover
 3.03 3.03 4.03 3.01 4.14
Inventory Turnover
 4.07 3.71 3.58 2.88 2.69
Fixed Asset Turnover
 2.48 2.55 3.04 2.64 2.43
Asset Turnover
 0.45 0.45 0.47 0.47 0.43
Working Capital Turnover Ratio
 8.17 10.06 8.51 12.26 11.63
Cash Conversion Cycle
 127.64 118.51 98.74 83.31 131.51
Days of Sales Outstanding
 158.20 140.68 87.34 78.01 84.24
Days of Inventory Outstanding
 89.73 98.44 101.96 126.54 135.50
Days of Payables Outstanding
 120.29 120.61 90.56 121.23 88.23
Operating Cycle
 247.94 239.12 189.30 204.55 219.74
Cash Flow Ratios
Operating Cash Flow Per Share
 0.44 0.43 0.54 0.69 0.54
Free Cash Flow Per Share
 0.24 0.22 0.36 0.55 0.07
CapEx Per Share
 0.20 0.21 0.18 0.14 0.47
Free Cash Flow to Operating Cash Flow
 0.54 0.52 0.67 0.79 0.13
Dividend Paid and CapEx Coverage Ratio
 1.18 0.92 1.24 2.44 0.93
Capital Expenditure Coverage Ratio
 2.18 2.07 3.05 4.87 1.15
Operating Cash Flow Coverage Ratio
 0.31 0.32 0.43 0.71 0.43
Operating Cash Flow to Sales Ratio
 0.12 0.12 0.16 0.23 0.20
Free Cash Flow Yield
5.05%2.82%7.59%13.74%1.51%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 14.79 22.43 6.81 7.46 7.84
Price-to-Sales (P/S) Ratio
 1.32 2.24 1.44 1.33 1.70
Price-to-Book (P/B) Ratio
 0.96 1.62 1.02 0.93 1.15
Price-to-Free Cash Flow (P/FCF) Ratio
 19.80 35.50 13.17 7.28 66.29
Price-to-Operating Cash Flow Ratio
 10.70 18.32 8.86 5.79 8.50
Price-to-Earnings Growth (PEG) Ratio
 -0.32 -0.45 0.23 -0.88 -0.59
Enterprise Value Multiple
 8.99 13.22 5.88 5.43 6.25
Enterprise Value
 20.98B 31.05B 19.91B 16.10B 19.32B
EV to EBITDA
 8.99 13.22 5.88 5.43 6.25
EV to Sales
 1.67 2.53 1.71 1.53 2.02
EV to Free Cash Flow
 25.03 40.09 15.60 8.35 78.62
EV to Operating Cash Flow
 13.53 20.69 10.49 6.64 10.08
Tangible Book Value Per Share
 3.49 3.49 3.63 3.71 3.25
Shareholders’ Equity Per Share
 4.93 4.86 4.70 4.32 3.99
Tax and Other Ratios
Effective Tax Rate
 0.19 0.17 0.14 0.19 0.17
Revenue Per Share
 3.59 3.51 3.33 3.00 2.70
Net Income Per Share
 0.32 0.35 0.70 0.54 0.59
Tax Burden
 0.81 0.83 0.87 0.80 0.83
Interest Burden
 0.83 0.85 0.99 0.91 0.93
Research & Development to Revenue
 0.04 0.04 0.05 0.05 0.06
SG&A to Revenue
 0.39 0.42 0.40 0.12 0.11
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 1.37 1.21 0.67 1.29 0.92
Currency in HKD